TargeOn SAS, a French company specialized in the development and commercialization of pediatric medicines, today announced that the company will be renamed ORPHELIA Pharma SA, effective October 9th, 2015. The articles of incorporation have been amended accordingly.

“The change of our company name is made to better reflect our activities in the field of rare pediatric indications” says Hugues Bienaymé, CEO and Founder of ORPHELIA Pharma. “This change is also the opportunity to launch our new website, to improve information on future developments of ORPHELIA Pharma and to facilitate the establishment of partnerships in Europe and North America. »

About ORPHELIA Pharma SA

Founded in 2007 by Hugues Bienaymé and previously known as TargeOn SAS, ORPHELIA Pharma’s mission is to develop and market new pediatric formulations of drugs already approved in Europe or in the USA. The company intends to use the regulation on pediatric medicines enacted in 2006 in Europe, including notably the PUMA (Pediatric Use Marketing Authorization) regulation. ORPHELIA Pharma holds several projects within the pediatric neurology field, notably anti-epileptic drugs. The most advanced project is currently in clinical development stage in France.

More info on www.orphelia-pharma.eu
contact@orphelia-pharma.eu; tel +33 (0) 1 42 77 08 18

1 octobre 2015

TargeOn SAS to become ORPHELIA Pharma SA
1 octobre 2015

TargeOn SAS, a French company specialized in the development and commercialization of pediatric medicines, today announced that the company will be renamed ORPHELIA Pharma SA, effective October 9th, 2015.
[ Read more ]
24 septembre 2015

ORPHELIA Pharma at Bio-Europe, Munich – Germany
24 septembre 2015

ORPHELIA Pharma will be present in Munich on November, 2 to 4 for the 21st annual BIO-Europe Congress. This event is the Europe’s largest partnering conference serving the global biotechnology industry. Do not hesitate to contact us to meet at this occasion. More info at: http://www.ebdgroup.com/bioeurope/index.php and http://www.partneringone.com Visit us at: http://www.orphelia-pharma.eu
[ Read more ]
20 septembre 2015

ORPHELIA Pharma at RARE 2015, Montpellier – France
20 septembre 2015

ORPHELIA Pharma will be present in Montpellier on November 26th and 27th for the RARE congress. This event brings together manufacturers, researchers, clinicians, patient organizations, regulatory authorities, and investors involved in the field of rare diseases. Do not hesitate to contact us to meet at this occasion. More info at: http://www.rare2015.com Visit us at: http://www.orphelia-pharma.eu
[ Read more ]
19 septembre 2015

ORPHELIA Pharma at CPhI, Madrid – Spain
19 septembre 2015

ORPHELIA Pharma will be present in Madrid on October 13th and 14th, 2015, in the number one Pharma event that brings together most international pharmaceuticals companies. Do not hesitate to contact us to meet at this occasion. More info at: http://www.cphi.com/europe/home Visit us at: http://www.orphelia-pharma.eu
[ Read more ]